fluconazole has been researched along with Hepatocellular Carcinoma in 4 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candida esophagitis was suspected." | 5.43 | Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report. ( Chen, KH; Chou, YH; Hsieh, CH; Lu, YF; Weng, MT, 2016) |
| "Candida esophagitis was suspected." | 1.43 | Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report. ( Chen, KH; Chou, YH; Hsieh, CH; Lu, YF; Weng, MT, 2016) |
| "Sterol profiling assay in the human hepatoma HepG2 cells revealed that compounds target human lanosterol 14alpha-demethylase (CYP51)." | 1.35 | Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51). ( Acimovic, J; Kocjan, D; Korosec, T; Rozman, D; Seliskar, M; Tacer, KF; Urleb, U, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korosec, T | 1 |
| Acimovic, J | 1 |
| Seliskar, M | 1 |
| Kocjan, D | 1 |
| Tacer, KF | 1 |
| Rozman, D | 1 |
| Urleb, U | 1 |
| Chen, KH | 1 |
| Weng, MT | 1 |
| Chou, YH | 1 |
| Lu, YF | 1 |
| Hsieh, CH | 1 |
| Korashy, HM | 2 |
| Shayeganpour, A | 1 |
| Brocks, DR | 2 |
| El-Kadi, AO | 2 |
4 other studies available for fluconazole and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51).
Topics: Anticholesteremic Agents; Binding Sites; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholesterol; C | 2008 |
Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Candidiasis; Carcinoma, Hepatocel | 2016 |
Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines.
Topics: Animals; Antifungal Agents; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Hepatocellular; | 2007 |
Induction of the NAD(P)H:quinone oxidoreductase 1 by ketoconazole and itraconazole: a mechanism of cancer chemoprotection.
Topics: Animals; Antifungal Agents; Carcinoma, Hepatocellular; Enzyme Activation; Enzyme Induction; Fluconaz | 2007 |